Efficacy of oral Ivermectin for treatment of Scabies
Phase 2
- Conditions
- Scabies.Scabies,sarcoptic itch
- Registration Number
- IRCT201205249844N1
- Lead Sponsor
- Vice chancellor for research, Tabriz University of Medical Sciences, Daneshgah Square.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Exclusion criteria: (Under 2years old; Pregnancy ; Positive history of seizure or epilepsy ; Positive history of immunodeficiency diseases; History of anti scabies drug usage in last month . ) (Nocturnal pruritus; Burrow or/and typical scabietic lesion on the classical sites; History of similar symptoms in their families . )
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to the treatment of the old lesion and absence of new lesion. Timepoint: 2, 4 weeks after treatment. Method of measurement: Physical examination and comparing old lesion picture with the site of lesion after medical treatment.
- Secondary Outcome Measures
Name Time Method Absence of pruritus of lesion. Timepoint: 2, 4 weeks after the treatment. Method of measurement: physical examination.